Your browser doesn't support javascript.
loading
Second primary malignancy after rituximab-containing immunochemotherapy for diffuse large B cell lymphoma.
Chinen, Yoshiaki; Tanba, Kazuna; Takagi, Ryo; Uchiyama, Hitoji; Uoshima, Nobuhiko; Shimura, Kazuho; Fuchida, Shin-Ichi; Kiyota, Miki; Nakao, Mitsushige; Tsukamoto, Taku; Shimura, Yuji; Kobayashi, Tsutomu; Horiike, Shigeo; Wada, Katsuya; Shimazaki, Chihiro; Kaneko, Hiroto; Kobayashi, Yutaka; Taniwaki, Masafumi; Yokota, Isao; Kuroda, Junya.
Afiliación
  • Chinen Y; Department of Hematology, Fukuchiyama City Hospital, Fukuchiyama, Japan.
  • Tanba K; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Takagi R; Department of Hematology, Fukuchiyama City Hospital, Fukuchiyama, Japan.
  • Uchiyama H; Department of Biostatistics, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Uoshima N; Department of Hematology, Japan Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Shimura K; Department of Hematology, Japan Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Fuchida SI; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan.
  • Kiyota M; Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
  • Nakao M; Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan.
  • Tsukamoto T; Department of Internal Medicine, Otsu Municipal Hospital, Otsu, Japan.
  • Shimura Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Kobayashi T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Horiike S; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Wada K; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Shimazaki C; Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan.
  • Kaneko H; Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
  • Kobayashi Y; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan.
  • Taniwaki M; Department of Hematology, Japan Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Yokota I; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan.
  • Kuroda J; Department of Biostatistics, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Leuk Lymphoma ; 61(14): 3378-3386, 2020 12.
Article en En | MEDLINE | ID: mdl-32852234
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Neoplasias Primarias Secundarias Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Neoplasias Primarias Secundarias Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos